Nothing Special   »   [go: up one dir, main page]

MX9202350A - Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol. - Google Patents

Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.

Info

Publication number
MX9202350A
MX9202350A MX9202350A MX9202350A MX9202350A MX 9202350 A MX9202350 A MX 9202350A MX 9202350 A MX9202350 A MX 9202350A MX 9202350 A MX9202350 A MX 9202350A MX 9202350 A MX9202350 A MX 9202350A
Authority
MX
Mexico
Prior art keywords
incrementing
compositions
skin penetration
glycerol monolinoleate
monolinoleate
Prior art date
Application number
MX9202350A
Other languages
English (en)
Spanish (es)
Inventor
Eun Soo Lee
Diane E Nedberge
Su Il Yum
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9202350A publication Critical patent/MX9202350A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9202350A 1991-05-20 1992-05-19 Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol. MX9202350A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70344091A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
MX9202350A true MX9202350A (es) 1992-11-01

Family

ID=24825405

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202350A MX9202350A (es) 1991-05-20 1992-05-19 Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.

Country Status (5)

Country Link
AU (1) AU2010392A (pt)
MX (1) MX9202350A (pt)
PT (1) PT100502A (pt)
WO (1) WO1992020377A1 (pt)
ZA (1) ZA923663B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
JP3786684B2 (ja) * 1992-05-13 2006-06-14 アルザ・コーポレーション オキシブチニンの経皮投与
FR2699406B1 (fr) * 1992-12-21 1995-03-10 Commissariat Energie Atomique Films à base de copolymères, leurs applications dans des systèmes transdermiques et leurs procédés de préparation.
WO1995009007A1 (en) * 1993-09-29 1995-04-06 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutynin
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
KR100483913B1 (ko) * 1996-07-03 2005-09-02 알자 코포레이션 약물송달장치
CA2259407C (en) * 1996-07-03 2006-04-04 Alza Corporation Drug delivery devices and process of manufacture
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) * 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
KR19990026792A (ko) 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6432446B2 (en) 2000-02-03 2002-08-13 Bridge Pharma, Inc. Non-arrhythmogenic metabolite of oxybutynin
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
CN101305994A (zh) 2000-04-26 2008-11-19 沃特森药物公司 最小化与奥昔布宁疗法有关的副作用
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
ATE545627T1 (de) 2003-05-23 2012-03-15 Bridge Pharma Inc Glattmuskelspasmolytika
US20160151321A1 (en) 2012-11-13 2016-06-02 Dinesh C. Patel Methods for the treatment of sialorrhea

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5618914A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
EP0103911A1 (en) * 1982-06-30 1984-03-28 THE PROCTER & GAMBLE COMPANY Emollient-containing topical pharmaceutical compositions
DE3779999T2 (de) * 1986-11-14 1992-12-10 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
JP2514995B2 (ja) * 1987-12-29 1996-07-10 旭電化工業株式会社 経皮、経粘膜による物質の吸収を促進する組成物
EP0555360A1 (en) * 1990-10-29 1993-08-18 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
AU2010392A (en) 1992-12-30
ZA923663B (en) 1993-01-27
WO1992020377A1 (en) 1992-11-26
PT100502A (pt) 1993-08-31

Similar Documents

Publication Publication Date Title
MX9202350A (es) Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
DZ2026A1 (fr) Compositions vaccinantes.
DZ2055A1 (fr) Compositions vaccinantes.
FI921598A0 (fi) Transdermal komposition.
NO20002078L (no) Komponenter til forbedret hudpenetrasjon
DE59607158D1 (de) Ballenpresse, insbesondere selbstfahrende Grossballenpresse
DE68913792D1 (de) Synergistische antimikrobielle Zusammensetzung.
DE69201648D1 (de) Katalysatorzusammensetzungen.
DE59005761D1 (de) Schalldämpfendes verbundwerk.
MX9102664A (es) Composiciones termofijas de recubrimiento que tienen dureza mejorada.
DE69206588D1 (de) Insektizide Zusammensetzungen.
FR2666226B1 (fr) Composition protectrice de la peau.
MX210800B (es) Mezclas insecticidas sinergicas.
DE69114350D1 (de) Strahlteilungs-/-vereinigungsvorrichtung.
DZ2283A1 (fr) Composition de vaccin.
NO900612D0 (no) Preservativ for vandige sammensetninger.
NO970193L (no) Ahesiver som er resistente mot hudinntrengingsforökere
FI941186A0 (fi) Neurotensiinimenetelmä verisuoniston vuotojen ehkäisemiseksi
NO890703D0 (no) Avtrekkings-sammensetning.
EE03731B1 (et) Sünergistliku toimega fungitsiidsed kompositsioonid
MX9200566A (es) Composiciones cosmeticas.
DE69002191D1 (de) Fettzusammensetzung.
IT9048359A0 (it) Barriera fonoassorbente vegetativa.
DE68910907D1 (de) Fungizide Zusammensetzungen.
DE69202685D1 (de) Silofutterschneider.